The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

Researchers engineer brain-infecting parasite into living drug delivery system By Darren Incorvaia Jul 29, 2024 2:55pm animal research parasite Blood-brain barrier Rett syndrome ...

NeOnc, Inc — a biotech company headed by neurosurgeon Dr. Thomas Chen — has developed a nasal brain delivery system that transports medications via a cranial-to-brain delivery, bypassing the ...

Developments in biotech can have an impact on humanity, the Earth and the animal kingdom, so it’s not surprising that headlines from the field are of immense interest.

Key Facts Precision said Thursday the FDA approved its Layer 7 Cortical Interface, a component of the company’s brain-computer interface implant that helps record, monitor and stimulate ...

Now, biotech company NeOnc has developed a new drug delivery system that just might revolutionize the lives of brain cancer patients.

--TransCode Therapeutics, Inc., the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the signing of a non-binding letter of intent and a ...

Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient last month and recorded neural activity, before removing it 10 minutes ...

As Siren Biotechnology Inc. develops a potential gene therapy to attack brain cancer, CEO Nicole Paulk had a fundraising revelation: Ask patients and their families if they want to invest in the ...

The Swedish biotech behind a groundbreaking Alzheimer’s treatment is in talks with partners for its new technology that allows drugs to cross the notoriously tricky blood-brain barrier.